API specialist Olon has announced the expansion of its pipeline with the addition of two products: pralsetinib and trilaciclib.
Italian active pharmaceutical ingredients specialist Olon has announced “a further significant expansion of its generic pipeline” with the addition of two kinase inhibitor “NIBs”: pralsetinib tablets and injectable trilaciclib.
Pralsetinib is indicated for treatment of non-small cell lung cancer, while trilaciclib is indicated to decrease the incidence of chemotherapy-induced...
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
Steffen Wagner has taken over as Stada’s head of Germany, adding to his existing responsibilities in Europe, after Eelco Ockers stepped down from the role. Ockers’ departure comes as German generics giant Stada restructures its business to bring its branded and consumer health interests into closer alignment as part of a more streamlined model.
Video provides a powerful way to help you prove your point. When you click Online Video, you can paste in the embed code for the video you want to add. You can also type a keyword to search online for the video that best fits your document.
